These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10050788)

  • 1. Agreement in pathologic interpretation of liver biopsy specimens in posttransplant hepatitis C infection.
    Younossi ZM; Boparai N; Gramlich T; Goldblum J; George P; Mayes J
    Arch Pathol Lab Med; 1999 Feb; 123(2):143-5. PubMed ID: 10050788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation.
    Regev A; Molina E; Moura R; Bejarano PA; Khaled A; Ruiz P; Arheart K; Berho M; Drachenberg CB; Mendez P; O'Brien C; Jeffers L; Tzakis A; Schiff ER
    Liver Transpl; 2004 Oct; 10(10):1233-9. PubMed ID: 15376303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens.
    Hunt J; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
    Liver Transpl; 2001 Dec; 7(12):1056-63. PubMed ID: 11753907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation.
    Petrovic LM; Villamil FG; Vierling JM; Makowka L; Geller SA
    Liver Transpl Surg; 1997 Jul; 3(4):398-406. PubMed ID: 9346770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retransplantation for recurrent hepatitis C.
    Sheiner PA; Schluger LK; Emre S; Thung SN; Lau JY; Guy SR; Schwartz ME; Miller CM
    Liver Transpl Surg; 1997 Mar; 3(2):130-6. PubMed ID: 9346726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.
    Hepatology; 1994 Jul; 20(1):15-20. PubMed ID: 8020885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
    Guerrero RB; Batts KP; Burgart LJ; Barrett SL; Germer JJ; Poterucha JJ; Wiesner RH; Charlton MR; Persing DH
    Mod Pathol; 2000 Mar; 13(3):229-37. PubMed ID: 10757333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience.
    Netto GJ; Watkins DL; Williams JW; Colby TV; dePetris G; Sharkey FE; Corless CL; Lewin D; Petrovic L; Sharma S; Kanel G; Theise N; West AB; Koehler A; Jhala NC; Lefkowitch J; Lezzoni J; Jennings LW; Tillery GW; Klintmalm GB;
    Arch Pathol Lab Med; 2006 Aug; 130(8):1157-62. PubMed ID: 16886238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis/cirrhosis after orthotopic liver transplantation.
    Tabatabai L; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 1999 Jan; 30(1):39-47. PubMed ID: 9923925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year.
    Caccamo L; Colledan M; Rossi G; Gridelli B; Maggi U; Vannelli A; Damilano I; Lucianetti A; Paone G; Gatti S; Reggiani P; Fassati LR
    Transpl Int; 1998; 11 Suppl 1():S212-20. PubMed ID: 9664982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
    Pei F; Zheng J; Du J; Zhong HH; Yang JP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in composition of inflammatory infiltrate in the course of hepatitis C reinfection and concomitant acute rejection after orthotopic liver transplantation.
    Ziarkiewicz-Wróblewska B; Wróblewski T; Ciszek M; Kalinowski P; Malejczyk J
    Ann Transplant; 2014 Jan; 19():41-50. PubMed ID: 24457607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of recurrent HCV infection after liver transplantation].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation.
    Berg T; Hopf U; Bechstein WO; Müller AR; Fukumoto T; Neuhaus R; Lobeck H; Neuhaus P
    Transplantation; 1998 Jul; 66(2):225-8. PubMed ID: 9701269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.
    Vasuri F; Malvi D; Gruppioni E; Grigioni WF; D'Errico-Grigioni A
    World J Gastroenterol; 2014 Mar; 20(11):2810-24. PubMed ID: 24659874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation.
    Huang EJ; Wright TL; Lake JR; Combs C; Ferrell LD
    Hepatology; 1996 Mar; 23(3):396-404. PubMed ID: 8617417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.
    Toniutto P; Fabris C; Avellini C; Minisini R; Bitetto D; Rossi E; Smirne C; Pirisi M
    World J Gastroenterol; 2005 Oct; 11(38):5944-50. PubMed ID: 16273604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.